WAVE Life Sciences Q1 EPS $(0.24) Misses $(0.21) Estimate, Sales $12.54M Miss $22.95M Estimate

WAVE Life Sciences (NASDAQ:WVE) reported quarterly losses of $(0.24) per share which missed the analyst consensus estimate of $(0.21) by 14.29 percent. This is a 11.11 percent increase over losses of $(0.27) per share from the same period last year. The company reported quarterly sales of $12.54 million which missed the analyst consensus estimate of $22.95 million by 45.37 percent. This is a 3.02 percent decrease over sales of $12.93 million the same period last year.